Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Esophagogastric Junction.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02625610
What this trial is testing

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Who this might be right for
Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction
EMD Serono Research & Development Institute, Inc. 499
Testing effectiveness (Phase 2)Looking for participantsNCT07551362
What this trial is testing

Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma
Beijing Biotech 36
Testing effectiveness (Phase 2)Looking for participantsNCT06962137
What this trial is testing

Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma MetastaticGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Universitaire Ziekenhuizen KU Leuven 100
Not applicableUnknownNCT06486545
What this trial is testing

Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Hunan Cancer Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT07655024
What this trial is testing

TAIC FOLFOX for Locally Advanced G/GEJA

Who this might be right for
Gastric Cancer (Diagnosis)Gastroesophageal Junction Adenocarcinoma
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 31
Not applicableStudy completedNCT04609813
What this trial is testing

Esophageal cAncer Screening Trial

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerGastroesophageal Junction Adenocarcinoma
Changhai Hospital 14,597
Not applicableLooking for participantsNCT06846996
What this trial is testing

Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

Who this might be right for
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction
Daiichi Sankyo 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507916
What this trial is testing

Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ctDNAGastric CancerGastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Fudan University 32
Testing effectiveness (Phase 2)UnknownNCT05964543
What this trial is testing

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

Who this might be right for
Gastroesophageal Junction (GEJ) Adenocarcinoma
QureBio Ltd. 72
Not applicableNot Yet RecruitingNCT05954117
What this trial is testing

Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia

Who this might be right for
Esophageal Adenocarcinoma
University Hospital, Clermont-Ferrand 60
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Large-scale testing (Phase 3)Looking for participantsNCT05188313
What this trial is testing

TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer

Who this might be right for
Esophageal CancerEsophageal Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 376
Large-scale testing (Phase 3)Study completedNCT03933449
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 123
Testing effectiveness (Phase 2)Looking for participantsNCT07311408
What this trial is testing

SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Jingdong Zhang 40
Large-scale testing (Phase 3)Study completedNCT02494583
What this trial is testing

Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Who this might be right for
Gastric Adenocarcinoma
Merck Sharp & Dohme LLC 763
Testing effectiveness (Phase 2)Study completedNCT03941873
What this trial is testing

Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer

Who this might be right for
Carcinoma, HepatocellularGastric/Gastroesophageal Junction Cancer
BeiGene 111
Very early researchLooking for participantsNCT06824363
What this trial is testing

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Who this might be right for
Solid Tumor, AdultMalignant Solid TumorStomach Adenocarcinoma+1 more
University of California, Irvine 34
Testing effectiveness (Phase 2)Study completedNCT03662659
What this trial is testing

An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers

Who this might be right for
Gastric CancerCancer of the StomachEsophagogastric Junction
Bristol-Myers Squibb 274
Testing effectiveness (Phase 2)Ended earlyNCT07040059
What this trial is testing

A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
HER 2 Positive Gastric CancerGastroesophageal Junction Adenocarcinoma
Aurigene Discovery Technologies Limited 2
Testing effectiveness (Phase 2)UnknownNCT00763646
What this trial is testing

Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Junction AdenocarcinomaGastroesophageal Junction Adenocarcinoma
McGill University 30
Next Page